Prabhat
Sandhya
Manthan
Samiksha
Anveshan
Archive
Prabhat
Dawn
Sandhya
Dusk
Manthan
Churning
Samiksha
Review
Anveshan
Investigation
Archive
Companies
About
Sign in
⌘K
Sign in
Subscribe
The Oorjita ledger
November 2025
27 pieces of research this month. Click any day to read.
Nov 2026
Mar 2026
Feb 2026
Jan 2026
Nov 2025
Oct 2025
Sept 2025
Aug 2025
Mon
Tue
Wed
Thu
Fri
Sat
Sun
1 ›
Samiksha: Navin Fluorine Q2 FY26: A Record Quarter at 32.5% Margins, All Three Engines Firing
2 ›
Manthan: When Domestic Money Said "Not On My Watch"
Anveshan: Alivus Life Sciences: Margins Expand Even After Losing PLI Benefits
Anveshan: Krishana Phoschem: India's Only Fully Integrated Private Phosphate Fertiliser Maker
Anveshan: Sanathan Textiles: Tripling Polyester Capacity in Punjab, 40% From Premium Yarns
Anveshan: Dharmaj Crop Guard: A Small Agrochemical Player Building Its Moats
Anveshan: KPI Green Energy: One of India's Fastest-Growing Renewable Players, Beyond Gujarat
3
4
5
6
7
8
9
10
11
12
13
14 ›
Sandhya: 88% Accurate: Gap-Down, Support Zone and Sector Calls Land as Forecast
15
16 ›
Manthan: Metals: Contrarian Setup or Value Trap?
17 ›
Prabhat: A Bullish Hammer and PSU Banks in Front: Can Nifty Hold Above 26,000?
Prabhat: India's Semiconductor Surge: From Design to Dominance
Samiksha: NATCO Pharma Q2 FY26: Life After Revlimid, and the Adcock Bet
Sandhya: FIIs Turn Net Buyers After Five Days of Selling, but Breadth Stays Narrow
18 ›
Prabhat: India's IPO Boom: Signal or Noise?
Prabhat: Six Days Up on Falling Volume: Momentum Exhaustion Above 26,000
Sandhya: The Six-Day Streak Ends: VIX Rises and a Bearish Engulfing Forms
Samiksha: Dharmaj Crop Guard Q2 FY26: Revenue Holds Up, Margins Slide to 9.2%
19 ›
Prabhat: India-US Trade Pact – The Alpha Beneath the Headlines
Prabhat: Third Rejection at 26,000: Weak Breadth and US Losses Point to a Cautious Open
Sandhya: Bank Nifty's Record Called Right, the 26,000 Ceiling Called Wrong
20 ›
Prabhat: Nvidia Lifts Indian IT as Nifty Reclaims 26,000; India-US 5G/6G Ties Deepen
Prabhat: FIIs Return With ₹1,581 Crore of Buying, but a Sub-12 VIX Signals Complacency
Sandhya: Market Breadth – Advance/Decline Ratio Confirms Healthy Rally
21 ›
Prabhat: Quality Over Beta: Why Low-Volatility Stocks Are Beating High-Beta Names
Prabhat: After the Breakout: Can Nifty Hold 26,150 Through Profit-Booking?
Anveshan: Mankind Pharma: India's No. 4 Drugmaker, Down 13.5%, Lags Peers on Profitability
Sandhya: Nifty Closes at 26,192 as Bank Nifty Steadies Near 59,300
22
23
24
25
26
27
28
29
30
The archive — every brief, day by day · Oorjita.AI